RTOG 0424 - A Phase II Study of a Temozolomide-Based Chemotherapy Regimen for High Risk Low Grade Gliomas.

Clinical Trial Categories

• Brain Cancer

Contact

The Rosenfeld Cancer Center at 215-481-2402